We investigated the vasorelaxant effects of MCI-154, a cardiotonic age
nt designed to target thin filaments in cardiac muscles in intact and
skinned vessels from guinea pigs. In normal Krebs-Henseleit solution,
MCI-154 (10(-7)-10(-4) M) inhibited the contractions induced by angiot
ensin II, (Ang II), endothelin-1 (ET-1), phenylephrine, and phorbol 12
-myristate 13-acetate (PMA) in a concentration-dependent manner in gui
nea pig aorta. In Ca2+-free solutions, ET-1 and PMA caused slowly deve
loping and sustained contractions in guinea pig aorta, whereas phenyle
phrine and caffeine induced transient contractions due to Ca2+ release
from the sarcoplasmic reticulum (SR). MCI-154 (10(-7)-10(-4) M) inhib
ited the contractile responses to ET-1 and PMA. MCI-154 also reduced t
he contraction induced by Ca2+ release from phenylehrine- and caffeine
-sensitive Ca2+ store sites. On the other hand, the relaxation respons
e to MCI-154 was not affected by the presence of methylene blue, a gua
nylate cyclase inhibitor or by the removal of endothelial cells. MCI-1
54 decreased the Ca2+-activated tension development in saponin-treated
skinned fibers from guinea pig femoral arteries. The effects of MCI-1
54 were not potentiated in the presence of protein kinase A (PKA), whe
reas those of cyclic AMP were potentiated, possibly because of lack of
protein kinase A. The present experiments demonstrate that MCI-154 in
hibits vascular contraction when the contractions are produced by any
of three mechanisms: protein kinase C (PKC) activation, Ca2+ mobilizat
ion from store sites, or sensitization of contractile elements by Ca2.